Percutaneous left ventricular advanced support for 'protected' complex high-risk transcatheter mitral valve repair: a case series.
Iacopo MuracaMatteo PennesiNazario CarrabbaFernando ScudieroAngela MiglioriniNiccolò MarchionniPier Luigi StefànoRenato ValentiPublished in: European heart journal. Case reports (2020)
In the two cases reported, PMVR with Impella CP assistance was feasible, safe and effective in the setting of severe mitral regurgitation associated with dilated and severe left ventricular dysfunction. Extending the concept of 'complex high-risk and indicated patients/procedures' (CHIP) from the environment of coronary intervention, a 'protected' approach could lead to improve technical feasibility and clinical outcome in structural interventions, as advocated for 'protected-percutaneous coronary intervention'.
Keyphrases
- left ventricular
- percutaneous coronary intervention
- acute myocardial infarction
- aortic stenosis
- ejection fraction
- coronary artery disease
- heart failure
- newly diagnosed
- randomized controlled trial
- hypertrophic cardiomyopathy
- early onset
- acute coronary syndrome
- coronary artery
- st segment elevation myocardial infarction
- physical activity
- mitral valve
- prognostic factors
- cardiac resynchronization therapy
- high throughput
- left atrial
- minimally invasive
- coronary artery bypass grafting
- antiplatelet therapy
- transcatheter aortic valve replacement